The PYC/Pfizer program is looking to develop vaccines through the use of phylomer peptides.
Vaccines are used to trigger an immune response within the body which builds a long term resistance.
Most phylomer peptides are too small (in numbers of amino acids) to trigger an immune response. So how will this program succeed?
Peptides are parts of proteins. Could many parts be joined to make a larger structure? A structure that would be anti-body size but have the building blocks of the original phylomer peptide. A structure that would trigger an immune response.
Share your thoughts
Cheers ST
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.37 |
Change
0.005(0.37%) |
Mkt cap ! $836.9M | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.44 | $1.34 | $546.6K | 401.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 11187 | $1.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.37 | 5000 | 1 |
View Market Depth
| Last trade - 15.23pm 16/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |